Parenteral Drug (India) announcements, page 9

Jun 2018

23 Jun · Board meeting
To consider and approve the financial results for the period ended March 31, 2018 and other business matters (opens in a new tab)
23 Jun · Notice Of Board Meeting Dated 29.06.2018 To Consider The Audited Financial Statements (Both Standalone And Consolidated) For The Financial Year Ended On 31St March, 2018
Dear Sir, This is to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of .... (opens in a new tab)
23 Jun · Notice Of Board Meeting On 29.06.2018 To Consider The Audited Financial Statements (Both Standalone And Consolidated) For The Financial Year Ended On 31St March, 2018
Dear Sir, This is to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of .... (opens in a new tab)
13 Jun · Management
Change in Director(s) of the company. (opens in a new tab)
13 Jun · Management
Dear Sir/Madam, The Board of Directors of the Company at their meeting held on Wednesday, the 13th day of June, 2018 at the Corporate office of the Company has taken on record .... (opens in a new tab)

Apr 2018

26 Apr · Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
Please find attached herewith, Certificate as per Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 duly certified by M/s. Archna Maheshwari & .... (opens in a new tab)
25 Apr · Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical .... (opens in a new tab)
21 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
13 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
13 Apr · Disclosure
Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
9 Apr · Disclosure
Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)

Feb 2018

16 Feb · Legal
Exchange had sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone limited review report not submitted. -2. Consolidated limited review report not submitted. The response of the Company is enclosed. (opens in a new tab)
15 Feb · Board meeting
Revised Outcome of Board Meeting dated 14th February, 2018 A meeting of the Board of Directors of the company was held on Wednesday, the 14th day of February, 2018 at 4.00 p.m. .... (opens in a new tab)
15 Feb · Legal
Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted. -2. Consolidated limited review report not submitted. The response of the Company is awaited.
14 Feb · Results
Financial results for the period ended December 31, 2017. (opens in a new tab)
14 Feb · Board meeting
Meeting of the Board of Directors of the company was held on Wednesday, the 14th day of February, 2018 at 4.00 p.m. at the Corporate Office of the Company at Indore and concluded at 08.05 .... (opens in a new tab)
8 Feb · Board meeting
Inter-alia to consider the Unaudited (Provisional) Financial Results of the Company on both Standalone and Consolidated basis for the third quarter of the financial year 2017-18 ended on December 31, 2017 and other items as per agenda of the meeting. (opens in a new tab)
8 Feb · Board meeting
This is to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company .... (opens in a new tab)
1 Feb · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....

Jan 2018

31 Jan · Meeting
Copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
30 Jan · Meeting
Copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
30 Jan · Meeting
Dear Sir, Pursuant to Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Companies (Management and Administration) Rules, 2014 as amended .... (opens in a new tab)
22 Jan · Statement Of Investor Complaints For The Quarter Ended 31St December 2017
Statement of Investors Complaints for the Quarter ended 31st December, 2017 in accordance with Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is as under: 1. No. of investor complaints pending at the beginning of quarter- NIL 2. No. of investor complaints received during the quarter- NIL 3. No. of investor complaints disposed off during the quarter- NIL 4. No. of investor complaints those remaining unresolved at the end of (opens in a new tab)
22 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....

Dec 2017

Oct 2017

28 Oct · Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
Please find attached herewith, Certificate as per Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 duly certified by M/s. Archna Maheshwari & .... (opens in a new tab)
28 Oct · Compliance Certificate For The Period Ended 30Th September, 2017
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical .... (opens in a new tab)
18 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
18 Oct · Statement Of Investors Complaints For The Quarter Ended 30Th September, 2017
Statement of Investors Complaints for the Quarter ended 30th September, 2017 in accordance with Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, .... (opens in a new tab)

Sep 2017

30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
29 Sep · Meeting
We hereby inform you that all the businesses .... (opens in a new tab)
29 Sep · Meeting
Copy Srutinizers report of Annual General Meeting held on September 29, 2017. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
29 Sep · Meeting
In compliance of Regulation 30 and Schedule III, Part A, Para A (13) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby .... (opens in a new tab)
29 Sep · Management
In compliance of Regulation 30 and Schedule III, Part A, Para A (7) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby .... (opens in a new tab)
29 Sep · Management
Change in Auditors of the company. (opens in a new tab)
29 Sep · Meeting
Proceedings of Annual General Meeting held on September 29, 2017 (opens in a new tab)
14 Sep · Results
Meeting of the Board of Directors of the company was held on Thursday, the 14th day of September, 2017 at 11.30 a.m. at the Corporate Office of the Company at Indore and concluded at .... (opens in a new tab)
14 Sep · Results
Financial results for the period ended June 30, 2017. (opens in a new tab)
7 Sep · Results
This is to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company .... (opens in a new tab)

Parenteral Drug (India) share news and announcements

Parenteral Drug (India) share news and announcements

Jun 2018

Apr 2018

Feb 2018

Jan 2018

Dec 2017

Oct 2017

Sep 2017